ewrobbins.com

User Tools

Site Tools

You are here: start » jc
jc

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
jc [2024/11/16 21:11] – adminjc [2025/04/24 13:52] (current) – admin
Line 21: Line 21:
       * **Significance**: First trial to show mortality benefit from MCS       * **Significance**: First trial to show mortality benefit from MCS
   * PULM   * PULM
 +    * [[https://doi.org/10.1056/NEJMoa2411664 | brensocatib for bronchiectasis]]
     * [[ https://www.nejm.org/doi/full/10.1056/NEJMoa2406673 | Depemokimab]]     * [[ https://www.nejm.org/doi/full/10.1056/NEJMoa2406673 | Depemokimab]]
     * [[https://www.nejm.org/doi/full/10.1056/NEJMoa2409712 | Inebilizumab for Treatment of IgG4-Related Disease]]     * [[https://www.nejm.org/doi/full/10.1056/NEJMoa2409712 | Inebilizumab for Treatment of IgG4-Related Disease]]
jc.txt · Last modified: 2025/04/24 13:52 by admin

Page Tools

Except where otherwise noted, content on this wiki is licensed under the following license: CC Attribution-Share Alike 4.0 International
CC Attribution-Share Alike 4.0 International Donate Powered by PHP Valid HTML5 Valid CSS Driven by DokuWiki